Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging

Details Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging

1994-03-28

1999-03-09

Kight, John

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

424 165, 424 111, 424 91, A61K 5100, A61M 3614

Patent

active

058796576

ABSTRACT:
This invention provides novel radiopharmaceuticals that are radiolabeled cyclic compounds containing carbocyclic or heterocyclic ring systems which act as antagonists of the platelet glycoprotein IIb/IIIa complex; to methods of using said radiopharmaceuticals as imaging agents for the diagnosis of arterial and venous thrombi; to novel reagents for the preparation of said radiopharmaceuticals; and to kits comprising said reagents.

REFERENCES:
patent: 4444690 (1984-04-01), Fritzberg et al.
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4670545 (1987-06-01), Fritzberg et al.
patent: 4673562 (1987-06-01), Davison et al.
patent: 4746505 (1988-05-01), Jones et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4879237 (1989-11-01), Ruoslahti et al.
patent: 4883862 (1989-11-01), Chervu et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4952562 (1990-08-01), Klein et al.
patent: 4963688 (1990-10-01), Bodor
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 4988621 (1991-01-01), Ruoslahti et al.
patent: 5023233 (1991-06-01), Nutt et al.
patent: 5026913 (1991-06-01), McBride et al.
patent: 5037631 (1991-08-01), Nosco
patent: 5041380 (1991-08-01), Ruoslahti et al.
patent: 5053503 (1991-10-01), Dean et al.
patent: 5080884 (1992-01-01), McBride et al.
patent: 5082930 (1992-01-01), Nicolotti et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5120829 (1992-06-01), Pierschbacher et al.
patent: 5144043 (1992-09-01), Dean et al.
patent: 5175256 (1992-12-01), Kasina et al.
patent: 5175343 (1992-12-01), Fritzberg et al.
patent: 5180816 (1993-01-01), Dean
patent: 5192380 (1993-03-01), Hanada et al.
patent: 5192745 (1993-03-01), Krstenansky et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5218128 (1993-06-01), Dean et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5236898 (1993-08-01), Krstenansky et al.
patent: 5250666 (1993-10-01), Gustavson et al.
patent: 5276147 (1994-01-01), Thornback et al.
patent: 5279811 (1994-01-01), Bergstein et al.
patent: 5279812 (1994-01-01), Krstenansky et al.
Fuster et al., JACC, vol. 5, No. 6, pp. 175B-183B (1985).
Rubenstein et al., American Heart Journal, pp. 363-367 (1981).
Hamm et al., JACC, vol. 10, No. 5, pp. 998-1004 (1987).
Davies et al., Circulation, vol. 73, No. 3, pp. 418-427 (1986).
Cerqueira et al., Circulation, vol. 85, No. 1, pp. 298-304 (1992).
Ord et al., Circulation, vol. 85, No. 1, pp. 288-297 (1992).
Wu Guo-xin et al., Chinese Medical Journal, vol. 105(7), pp. 553-559 (1992).
D'Amico, Emergency Medicine Clinics of North America, Focus on Radiology: Part II, vol. 10, No. 1, pp. 121-132 (1992).
Haddad et al., Gastrointestinal Radiology, vol. 17, pp 34-40 (1992).
Phillps et al., Cell, vol. 65, pp. 359-362 (1991).
Koblik et al., Seminars in Nuclear Medicine, vol. 19, No. 3, pp. 221-237 (1989).
Macovski, A., Medical Imaging Systems, Information and Systems Science Series, pp. 145-172, Kailath, T., ed., Prentice-Hall, Inc., Englewood Cliffs, NJ (1983).
Pak et al., J. Nucl. Med., vol. 30, No. 5, p. 793, 36th Ann. Meet. Soc. Nucl. Med. (1989).
Epps et al., J. Nucl. Med., vol. 30, No. 5, p. 794, 36th Ann. Meet. Soc. Nucl. Med. (1989).
Pak et al., J. Nucl. Med., vol. 30, No. 5, p. 934, 36th Ann. Meet. Soc. Nucl. Med. (1989).
Dean et al., J. Nucl. Med., vol. 30, No. 5, p. 934, 36th Ann. Meet. Soc. Nucl. Med. (1989).
Chumpradit et al., J. Med. Chem., vol. 34, pp. 877-883 (1991).
Seevers et al., Chem. Rev., vol. 82, pp. 575-590 (1982).
Wilson et al., J. Org. Chem, vol. 51, pp. 4833-4836 (1986).
D'Souza et al., Journal of Biological Chemistry, vol. 265, No. 6, pp. 3440-3446 (1990).
Arora et al., J. Med. Chem, vol. 30, pp. 918-924 (1987).
Chumpradit et al., J. Med. Chem, vol. 32, pp. 1431-1435 (1989).
Eckelman et al., Journal of Nuclear Medicine, vol. 20, pp. 350-357 (1979).
Sekiya et al., Chemical & Pharmaceutical Bulletin, vol. 11, pp. 551-553 (1963).
Felder et al., Helv. Chim. Acta, vol. 48, No. 25, pp. 259-274 (1965).
Kulin et al., Can. J. Chem., vol. 51, pp. 687-693 (1973).
Merkushev, Synthesis, pp. 923-937 (Dec. 1988).
Ellis et al., Aust. J. Chem, vol. 26, pp. 907-911 (1973).
Koch et al., Chem. Ber., vol. 124, pp. 2091-2100 (1991).
Hartwell, Organic Syntheses Collective, vol. 3, pp. 185-189 (1955).
Lucas et al., Organic Syntheses, vol. 2, pp. 351-357 (1943).
Schiemann et al., Organic Syntheses, vol. 2, pp. 299-301 (1943).
Buck et al., Organic Syntheses, vol. 2, pp. 130-138 (1943).
Wolf et al., "Synthesis of Radiopharmaceuticals and Labeled Compounds Using Short-Lived Isotopes", in Radiopharmaceuticals and Labeled Compounds, vol. 1, pp. 345-381 (1973).
Wityak et al (1995). Bioorganic & Medicinal Chemistry, Letters, vol. 5, No. 18, pp. 2097-2100, Synthesis and Antiplatelet Activity of DMP 757 Analogs.
Mihara et al (1995). Tetrahedron Letters, vol. 36, No. 27, pp. 4837-4840. Efficient Preparation of Cyclic Peptide Mixtures by Solid Phase Synthesis and Cyclization Cleavage with Oxime Resin.
Jackson et al (1994). J. Am. Chem. Soc, vol. 116, pp. 3220-3230. "Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIlb/III9".
Bach et al (1994), vol. 116, pp. 3207-3219. "Structural Studies of a Family of High Affinity Ligands for GPIIb/IIIa".

Affiliated with

Also associated with

Rating

Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1317788